8 December 2011
Last updated at 02:06
By Shilpa Kannan
BBC News, Delhi
As more and more patents expire Indian drug makers like Ranbaxy could start seeing major profits with their generic versions
The "patent cliff" has begun. Dreaded by leading pharmaceutical companies of the West for years now, it could potentially make millions of dollars
No comments:
Post a Comment